Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Christopher H. Yaen

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 15 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 15 Dec, 2021
Edits made to:
Infobox (-136 properties)
Infobox
Patent primary examiner of
‌
US Patent 7160679 Method of diagnosing, monitoring, and staging lung cancer
‌
US Patent 7160987 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
‌
US Patent 7176179 Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
‌
US Patent 7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
‌
US Patent 7186515 Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof
‌
US Patent 7192728 Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity
‌
US Patent 7201905 Bi-functional cancer treatment agents
‌
US Patent 7202342 Compositions and methods for the therapy and diagnosis of prostate cancer
‌
US Patent 7208146 Methods of treating lymphoma and leukemia
‌
US Patent 7214477 Layered device with capture regions for cellular analysis
‌
US Patent 7230083 Anti-alphabeta3 humanized monoclonal antibodies
‌
US Patent 7247438 Methods of identifying agents which enhance caspase activity
‌
US Patent 7250394 Treatment of glial tumors with glutamate antagonists
‌
US Patent 7250498 Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer
‌
US Patent 7253269 Modified cDNA of rat
‌
US Patent 7255854 Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases
‌
US Patent 7256252 Methods for detecting cell apoptosis
‌
US Patent 7256274 Apoptin-associating protein
‌
US Patent 7279156 Apoptotic entities for use in treatment of endothelium dysfunction disorders
‌
US Patent 7279292 Methods for diagnosis of low grade astrocytoma
‌
US Patent 7282345 C-erbB-2 external domain: GP75
‌
US Patent 7285382 Compositions and methods for treatment of cancer
‌
US Patent 7285649 Isolated nucleic acids, vectors and host cells encoding ErbB3 antibodies
‌
US Patent 7306921 Diagnostic and monitoring methods for cancer
‌
US Patent 7309492 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus
‌
US Patent 7351805 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
‌
US Patent 7357915 Method of imaging cell death in vivo
‌
US Patent 7357928 Method for the diagnosis and prognosis of malignant diseases
‌
US Patent 7358329 Antagonists to chaperonin 10
‌
US Patent 7371376 Anti-ErbB2 antibodies
‌
US Patent 7390634 β-netrin and uses thereof
‌
US Patent 7393932 Endothelial cell expression patterns
‌
US Patent 7402317 Anti-cancer vaccine
‌
US Patent 7408021 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
‌
US Patent 7416885 Proliferated cell lines and uses thereof
‌
US Patent 7420036 Anti-angiogenic polypeptides
‌
US Patent 7452534 Recombinant anti-CD4 antibodies for human therapy
‌
US Patent 7459537 Anti-lymphotoxin-β receptor antibodies as anti-tumor agents
‌
US Patent 7462458 Methods of detecting ovarian neoplasia
‌
US Patent 7468425 None
‌
US Patent 7479543 Reshaped human antibody to human interleukin-6 receptor
‌
US Patent 7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
‌
US Patent 7501501 MHC-Class II restricted melanoma antigens and their use in therapeutic methods
‌
US Patent 7504102 Anti-α
‌
US Patent 7507401 Anti-cancer agent
‌
US Patent 7507407 Immunoliposomes that optimize internationalization into target cells
‌
US Patent 7507410 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
‌
US Patent 7507805 Cell death-inducing fused gene acting specifically on cancer and gene product thereof
‌
US Patent 7507807 TWEAK receptor
‌
US Patent 7514546 Antibodies
‌
US Patent 7517526 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
‌
US Patent 7517948 Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof
‌
US Patent 7517950 Tumor antigen based on products of the tumor suppressor gene WT1
‌
US Patent 7517962 TWEAK receptor
‌
US Patent 7521045 Methods of inhibiting metastasis
‌
US Patent 7524495 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation
‌
US Patent 7524935 Sequences characteristic of hypoxia-regulated gene transcription
‌
US Patent 7531625 β netrin and uses thereof
‌
US Patent 7531629 Tumor associated antigen peptides and use of same as anti-tumor vaccines
‌
US Patent 7537901 Extracellular serine protease
‌
US Patent 7541141 Method of using estrogen-related receptor alpha (ERRα) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRα as a therapeutic target for the treatment of breast cancer
‌
US Patent 7541150 Method for the diagnosis and prognosis of malignant diseases
‌
US Patent 7550141 Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids
‌
US Patent 7557196 hGC-1, a gene encoding a member of the olfactomedin-related protein family
‌
US Patent 7560440 Regulation of angiogenesis with zinc finger proteins
‌
US Patent 7560543 Method of determining a chemotherapeutic regimen based on
‌
US Patent 7569538 Immunization of an individual against carcinomas and the preliminary stages thereof
‌
US Patent 7569672 Antibodies that bind to EphA2 and methods of use thereof
‌
US Patent 7572891 Kidney-specific tumor vaccine directed against kidney tumor antigen G-250
‌
US Patent 7576177 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
‌
US Patent 7579147 Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease
‌
US Patent 7582287 Method for treating cervical cancer
‌
US Patent 7585512 Composition and method of using tumor cells
‌
US Patent 7585946 Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions
‌
US Patent 7585952 Human mini-antibody cytotoxic for tumor cells which express the ErbB2 receptor
‌
US Patent 7589173 Methods for diagnosing cancer and decreasing metastasis by cancer cells
‌
US Patent 7598045 C-type LECTIN transmembrane antigen expressed in human prostate cancer and uses thereof
‌
US Patent 7598225 Generation of immune response to prostate-specific antigen (PSA)
‌
US Patent 7598349 Antibodies to peptide fragments having cell death-inhibitory activity
‌
US Patent 7601359 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins
‌
US Patent 7601505 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
‌
US Patent 7601697 Compounds for eliciting or enhancing immune reactivity to HER-2/
‌
US Patent 7601698 Polypeptide
‌
US Patent 7601806 RTVP-GliPR-like compositions and methods for the detection, treatment and prevention of prostate cancer
‌
US Patent 7605140 Regulation of angiogenesis with zinc finger proteins
‌
US Patent 7608685 Tumor antigen based on products of the tumor suppressor gene WT1
‌
US Patent 7612172 Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
‌
US Patent 7615612 Polypeptide
‌
US Patent 7618785 Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
‌
US Patent RE41007 Method for diagnosing selected adenocarcinomas
‌
US Patent 7622265 Methods and compositions for modulating prostasin
‌
US Patent 7625558 Compositions and methods of treating tumors
‌
US Patent 7626003 Genetically engineered cDNA of rat
‌
US Patent 7626008 Anti-angiogenic polypeptides
‌
US Patent 7662378 Antibody therapy
‌
US Patent 7662770 Low molecular weight protein tyrosine phosphatase (LMW-PTP) as a diagnostic and therapeutic target
‌
US Patent 7666389 Method of imaging cell death in vivo
‌
US Patent 7666669 Polypeptide
‌
US Patent 7666998 Cell growth inhibitor containing anti-PepT antibody
‌
US Patent 7670599 YKL-40 as a marker and prognostic indicator for cancers
‌
US Patent 7670601 Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
‌
US Patent 7670611 Cancer immunotherapy with semi-allogeneic cells
‌
US Patent 7674459 Treatment of cancer with a novel anti-IL13 monoclonal antibody
‌
US Patent 7674460 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
‌
US Patent 7674579 Apoptosis-based evaluation of chemosensitivity in cancer patients
‌
US Patent 7674619 ADAM-9 modulators
‌
US Patent 7682607 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
‌
US Patent 7682609 Protein formulation
‌
US Patent 7682785 Method for predicting effectiveness of chemotherapy using anticancer agent
‌
US Patent 7687465 Therapeutic cancer vaccine
‌
US Patent 7687606 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
‌
US Patent 7691372 Use of antibodies for the vaccination against cancer
‌
US Patent 7691566 Compositions and methods for treatment of cancer
‌
US Patent 7696336 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
‌
US Patent 7700546 Therapeutic agent for cancer
‌
US Patent 7700738 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
‌
US Patent 7705130 Antibodies directed to HER-3 and uses thereof
‌
US Patent 7705131 Method for diagnosing selected adenocarcinomas
‌
US Patent 7713704 MN gene and protein
‌
US Patent 7714108 Mammalian tumor susceptibility gene products and their uses
‌
US Patent 7718762 Cancer vaccines containing epitopes of oncofetal antigen
‌
US Patent 7723475 RTVP-GliPR-like compositions and methods for the detection, treatment and prevention of prostate cancer
‌
US Patent 7732131 Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor
‌
US Patent 7732144 Method of determining a chemotherapeutic regimen based on
‌
US Patent 7732564 Serum tumor marker in rodent prostate cancer models
‌
US Patent 7741025 Method of diagnosing lung cancer using BGS42
‌
US Patent 7741040 Methods and compositions for detecting cancers
‌
US Patent 7741275 Agents and use thereof
‌
US Patent 7741433 Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof
‌
US Patent 7741440 Apoptin-associating protein
‌
US Patent 7744891 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
‌
US Patent 7745399 Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof
‌
US Patent 7745572 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
‌
US Patent 7749714 Compositions and methods for diagnosing and treating prostate cancer
‌
US Patent 7763719 Variants of humanized anti-carcinoma MAb CC49
‌
US Patent 7776328 Antibodies that bind to EphA2 and methods of use thereof
Edits on 5 Dec, 2021
Golden AI profile picture
Golden AI
edited on 5 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7776328 Antibodies that bind to EphA2 and methods of use thereof
Golden AI profile picture
Golden AI
edited on 5 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7763719 Variants of humanized anti-carcinoma MAb CC49
Golden AI profile picture
Golden AI
edited on 5 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7749714 Compositions and methods for diagnosing and treating prostate cancer
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7745399 Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7741440 Apoptin-associating protein
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7741433 Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7741275 Agents and use thereof
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7741040 Methods and compositions for detecting cancers
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7741025 Method of diagnosing lung cancer using BGS42
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7732564 Serum tumor marker in rodent prostate cancer models
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7732144 Method of determining a chemotherapeutic regimen based on
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits on 4 Dec, 2021
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7718762 Cancer vaccines containing epitopes of oncofetal antigen
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7714108 Mammalian tumor susceptibility gene products and their uses
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7713704 MN gene and protein
Golden AI profile picture
Golden AI
edited on 4 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7705131 Method for diagnosing selected adenocarcinomas

Find more people like Christopher H. Yaen

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo